DoH Policies screened during the period: 1st January 2018 - 31st March 2018

In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact assessment (EQIA).

Documents

NICE Technology Appraisal TA493 - Cladribine tablets for treating relapsing-remitting multiple sclerosis
PDF (64 KB)

NICE Technology Appraisal TA494 - Naltrexone–bupropion for managing overweight and obesity
PDF (62 KB)

NICE Technology Appraisal TA495 - Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
PDF (86 KB)

NICE Technology Appraisal TA496 - Ribociclib in combination with an aromatase inhibitor for previously untreated advanced or metastatic hormone receptor-positive, HER2-negative breast cancer
PDF (87 KB)

NICE Clinical Guideline CG28 - Depression in children and young people: identification and management
PDF (65 KB)

NICE Clinical Guideline NG77 - Cataracts in adults: management
PDF (65 KB)

NICE Clinical Guideline NG78 - Cystic fibrosis: diagnosis and management
PDF (64 KB)

NICE Clinical Guideline NG81 - Glaucoma: diagnosis and management (updates & replaces CG85
PDF (64 KB)

NICE Technology Appraisal TA497 - Golimumab for treating non-radiographic axial spondyloarthritis
PDF (63 KB)

NICE Clinical Guideline NG80 - Asthma: diagnosis, monitoring and chronic asthma management
PDF (66 KB)

NICE Technology Appraisal TA498 - Lenvatinib with everolimus for previously treated advanced renal cell carcinoma
PDF (63 KB)

NICE Technology Appraisal TA499 - Glecaprevir–pibrentasvir for treating chronic hepatitis C
PDF (63 KB)

NICE Technology Appraisal TA502 - Ibrutinib for treating relapsed or refractory mantle cell lymphoma
PDF (64 KB)

NICE Technology Appraisal TA503 - Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer
PDF (63 KB)

NICE Technology Appraisal TA500 - Ceritinib for untreated ALK-positive non-small-cell lung cancer
PDF (86 KB)

NICE Technology Appraisal TA501 - Intrabeam radiotherapy system for adjuvant treatment of early breast cancer
PDF (65 KB)

NICE Technology Appraisal TA504 - Pirfenidone for treating idiopathic pulmonary fibrosis (review of TA282)
PDF (70 KB)

NICE Technology Appraisal TA506 - Lesinurad for treating chronic hyperuricaemia in people with gout
PDF (63 KB)

NICE Technology Appraisal TA508 - Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee
PDF (68 KB)

NICE Technology Appraisal TA507 - Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C
PDF (67 KB)

NICE Clinical Guideline NG83 - Oesophago-gastric cancer: assessment and management in adults
PDF (64 KB)

Proposed Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018 and underpinning policy
PDF (234 KB)

Help viewing documents